Wolkow Pawel P, Niewczas Monika A, Perkins Bruce, Ficociello Linda H, Lipinski Boguslaw, Warram James H, Krolewski Andrzej S
Section on Genetics & Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA.
J Am Soc Nephrol. 2008 Apr;19(4):789-97. doi: 10.1681/ASN.2007050556. Epub 2008 Feb 6.
Progressive renal function decline begins in one third of patients with microalbuminuria and type 1 diabetes. This study examined whether this decline is associated with elevated excretion of inflammatory markers in urine. Five inflammatory markers (IL-6, IL-8, monocyte chemoattractant protein-1, interferon-gamma-inducible protein (IP-10), and macrophage inflammatory protein-1delta) were measured in urine samples from the First Joslin Study of the Natural History of Microalbuminuria in Type 1 Diabetes, a cohort recruited in 1991. Samples were obtained from 43 participants with microalbuminuria and stable renal function (nondecliners), from 28 with microalbuminuria and early progressive renal function decline (decliners), and from 74 with normoalbuminuria and stable renal function (reference). Urinary concentrations of all five inflammatory markers were significantly higher in decliners than in nondecliners, who were similar to the reference group. Multivariate analysis revealed that those with more than two markers elevated were more than five times as likely to have early progressive decline of renal function. In contrast, serum concentrations of C-reactive protein, IL-8, and macrophage inflammatory protein-1delta did not differ between decliners and nondecliners. These results support the hypothesis that inflammatory processes in the kidney contribute to the progression of nephropathy in patients with type 1 diabetes.
三分之一的微量白蛋白尿合并1型糖尿病患者会出现进行性肾功能下降。本研究旨在探讨这种肾功能下降是否与尿中炎症标志物排泄增加有关。在1991年招募的1型糖尿病微量白蛋白尿自然史首次乔斯林研究队列的尿样中,检测了五种炎症标志物(白细胞介素-6、白细胞介素-8、单核细胞趋化蛋白-1、干扰素-γ诱导蛋白(IP-10)和巨噬细胞炎症蛋白-1δ)。样本取自43例微量白蛋白尿且肾功能稳定(非下降者)、28例微量白蛋白尿且早期肾功能进行性下降(下降者)以及74例尿白蛋白正常且肾功能稳定(参照组)的参与者。下降者尿中所有五种炎症标志物的浓度均显著高于非下降者,而非下降者与参照组相似。多变量分析显示,有两种以上标志物升高的患者肾功能早期进行性下降的可能性是其他人的五倍多。相比之下,下降者和非下降者的血清C反应蛋白、白细胞介素-8和巨噬细胞炎症蛋白-1δ浓度并无差异。这些结果支持了以下假说:肾脏中的炎症过程会促使1型糖尿病患者的肾病进展。